Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism
CompletedOBSERVATIONAL
Enrollment
63
Participants
Timeline
Start Date
September 1, 2017
Primary Completion Date
February 11, 2021
Study Completion Date
February 11, 2021
Conditions
Parkinson DiseaseAtypical ParkinsonismDystonia
Trial Locations (1)
93009
Avicenne Hospital, Bobigny
All Listed Sponsors
collaborator
Assistance Publique - Hôpitaux de Paris
OTHER
lead
Hospital Avicenne
OTHER
NCT04948684 - Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism | Biotech Hunter | Biotech Hunter